Aaron Osborne's most recent trade in Adverum Biotechnologies Inc was a trade of 150,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 16, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adverum Biotechnologies Inc | Aaron Osborne | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) |